Medpace | Sustainability Performance
Provides clinical research services to the pharmaceutical, biotechnology, and medical device industries. Focuses on advancing drug and device development with comprehensive support.
1992
United States
5,001 - 10,000 employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4789
Overallⓘ#951
in United Statesⓘ#104
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Financial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Medpace Holdings Inc, US clinical research organization, has faced multiple US shareholder class actions over alleged inadequate disclosure of biotech customer demand changes affecting share price, plus the contested 2024 sustained share price volatility amid US small-biotech customer concentration risks affecting institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
7-10
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.